Muhammad Alaa Eldeen
Impact in
- Geriatrics and Gerontology top 10%
-
- vaccines and immunoinformatics approaches
- Epigenetics and DNA Methylation
Papers in
-
- vaccines and immunoinformatics approaches 8
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Refaat A. Eid (34 shared papers)Mohamed A. Soltan (18 shared papers)Mohamed Samir Ahmed Zaki (23 shared papers)Attalla F. El‐kott (10 shared papers)Mubarak Al‐Shraim (10 shared papers)Eman Fayad (16 shared papers)Ahmed A. Al‐Karmalawy (2 shared papers)Samy M. Eleawa (6 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)Current Issues in Molecular Biology (2 papers)Vaccines (2 papers)Frontiers in Immunology (2 papers)Clinical and Experimental Pharmacology and Physiology (2 papers)
- Partner nations
- EgyptSaudi ArabiaKuwait
In The Last Decade
Muhammad Alaa Eldeen
38 papers receiving 547 citations
Peers
Comparison fields: 5 of 85
- Geriatrics and Gerontology 21
- Molecular Biology 261
- Cancer Research 44
- Oncology 74
- Endocrine and Autonomic Systems 18
Countries citing papers authored by Muhammad Alaa Eldeen
This map shows the geographic impact of Muhammad Alaa Eldeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Alaa Eldeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Alaa Eldeen more than expected).
Fields of papers citing papers by Muhammad Alaa Eldeen
This network shows the impact of papers produced by Muhammad Alaa Eldeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Alaa Eldeen. The network helps show where Muhammad Alaa Eldeen may publish in the future.
Co-authors
The 25 scholars most cited alongside Muhammad Alaa Eldeen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2021 | 66 | |
| 3 | 2023 | 41 | |
| 4 | 2021 | 37 | |
| 5 | 2021 | 29 | |
| 6 | 2020 | 26 | |
| 7 | 2024 | 22 | |
| 8 | 2020 | 22 | |
| 9 | 2022 | 21 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 17 | |
| 12 | 2018 | 17 | |
| 13 | 2021 | 17 | |
| 14 | 2022 | 15 | |
| 15 | 2022 | 15 | |
| 16 | 2022 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2017 | 10 | |
| 19 | 2023 | 9 | |
| 20 | 2022 | 9 |
About Muhammad Alaa Eldeen
Muhammad Alaa Eldeen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Nutrition and Dietetics, having authored 43 papers that have together received 552 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (8 papers), Epigenetics and DNA Methylation (5 papers), Adipose Tissue and Metabolism (4 papers), Ferroptosis and cancer prognosis (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Geriatrics and Gerontology (21 citations), Molecular Biology (261 citations), Cancer Research (44 citations), Oncology (74 citations) and Endocrine and Autonomic Systems (18 citations). Muhammad Alaa Eldeen has collaborated with scholars based in Egypt, Saudi Arabia and Kuwait. Frequent co-authors include Refaat A. Eid, Mohamed A. Soltan, Mohamed Samir Ahmed Zaki, Attalla F. El‐kott, Mubarak Al‐Shraim, Eman Fayad, Ahmed A. Al‐Karmalawy, Samy M. Eleawa, Hussain Aldera and Mahmoud A. Alkhateeb. Their work appears in journals such as International Journal of Molecular Sciences, Current Issues in Molecular Biology, Vaccines, Frontiers in Immunology and Clinical and Experimental Pharmacology and Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.